Investments, Funding & Disinvestment

Currently, about five in 10 women diagnosed with breast cancer in Africa survive for at least five years after diagnosis.

Discussions covered the use of responsible AI to improve healthcare workflows, wearable devices for continuous health monitoring, health informatics and ambient listening technologies.

The agreement covers licensing, development, manufacturing and commercialisation of the candidate, which is currently in the early stages of development.

The consignment, which originated in neighboring Sierra Leone, contained 44 cartons of Reality Extra D, a pharmaceutical product containing diclofenac sodium 50 mg.

The ACUVUE OASYS MAX 2 Week lens is part of the wider ACUVUE OASYS MAX portfolio, which J&J developed to provide advanced options for people who use reusable contact lenses.

Novadip will use the proceeds to advance NVD003, its lead autologous cell-based therapy, through late-stage clinical development and regulatory preparation.

The five-day meeting in Geneva focused on developing the Pathogen Access and Benefit-Sharing (PABS) annex to the WHO Pandemic Agreement, with governments working towards a system that is practical, equitable and feasible to implement.

The proposed expansion would allow its use in adolescents aged 12 to 17 years with moderate to severe chronic hand eczema (CHE) when topical corticosteroids are inadequate or inappropriate.

Under the agreement, 1ST Biotherapeutics will receive US$1.8 million upfront and an additional US$1.8 million payment in the near term.

The projects form part of Reckitt’s broader effort to increase production and bring research activities closer to its U.S. commercial operations.